Hoth Therapeutics, Inc. (HOTH) Social Stream



Hoth Therapeutics, Inc. (HOTH): $0.84

0.01 (+1.11%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

HOTH THERAPEUTICS INC (HOTH) Price Targets From Analysts

Use the tables below to see what analysts covering HOTH THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-06-18 1 $10 $10 $10 $1.35 640.74%
2022-04-14 1 $5 $5 $5 $1.35 270.37%
2022-05-27 1 $4 $4 $4 $1.35 196.3%
2022-12-30 2 $100 $33 $66.5 $1.35 4825.93%
2023-08-23 2 $14 $5 $9.5 $1.35 603.7%
2023-09-14 2 $7.5 $5 $6.25 $1.35 362.96%
2023-11-20 2 $6.5 $5 $5.75 $1.35 325.93%

Price Target Last Issued May 27, 2022

The Trend in the Analyst Price Target


HOTH's average price target has moved up $0.75 over the prior 20 months.

HOTH reports an average of 338.58% for its upside potential over the past 32 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-10 2 14.0 5 9.50 2.03 367.98%
2023-08-23 2 14.0 5 9.50 2.40 295.83%
2023-09-14 2 7.5 5 6.25 1.77 253.11%
2023-11-20 2 6.5 5 5.75 1.07 437.38%

HOTH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


HOTH's average broker recommendation rating improved by 1 over the prior 26 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HOTH as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, HOTH THERAPEUTICS INC's number of analysts covering the stock is higher than 16.98% of them.
  • HOTH has a higher upside potential (average analyst target price relative to current price) than 950.89% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, HOTH THERAPEUTICS INC's variance in analysts' estimates is lower than -237.23% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, HOTH THERAPEUTICS INC's average analyst price target is higher than 394.5% of them.

In the Pharmaceutical Products industry, TLSA, RVPH, and ADIL are the three stocks most similar to HOTH THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for HOTH? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!